Kenji Chamoto

8PUBLICATIONS
47CO-AUTHORS
Cancer cell biologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 20, 2026
Multifunctional Role of Mitochondrial Fatty Acid Oxidation in Cancer Immunotherapy and Aging.

|Feb 17, 2026
Phenotype of circulating tumor-reactive T cells predicts immune checkpoint inhibitor response in non-small cell lung cancer.

Katsuhiro Ito, Kei Iida, Tomoko Hirano

|Jan 07, 2026
Active aldehydes accelerate CD8+ T cell exhaustion by metabolic alteration in the tumor microenvironment.

Yasuharu Haku, Koji Kitaoka, Koki Ichimaru

|Dec 05, 2025
Chimeric MHC class I- and II-restricted non-self epitopes broaden antitumor T cell reactions.

Rongsheng Zhang, Rong Ma, Merrin M L Leong

|Dec 14, 2022
Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancer.

Kentaro Tanaka, Kenji Chamoto, Sho Saeki

|Nov 30, 2022
Chemical induction of splice-neoantigens attenuates tumor growth in a preclinical model of colorectal cancer.

Shingo Matsushima, Masahiko Ajiro, Kei Iida

Pageof 2

Frequent Collaborators

6 joint publications

Tasuku Honjo

3 joint publications

Tomoko Hirano

3 joint publications

Tomonori Yaguchi

3 joint publications

Kei Iida